JP2005502339A5 - - Google Patents

Download PDF

Info

Publication number
JP2005502339A5
JP2005502339A5 JP2003521262A JP2003521262A JP2005502339A5 JP 2005502339 A5 JP2005502339 A5 JP 2005502339A5 JP 2003521262 A JP2003521262 A JP 2003521262A JP 2003521262 A JP2003521262 A JP 2003521262A JP 2005502339 A5 JP2005502339 A5 JP 2005502339A5
Authority
JP
Japan
Prior art keywords
allergen
cysteine
seq
recombinant
derp1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003521262A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005502339A (ja
Filing date
Publication date
Priority claimed from GBGB0120150.8A external-priority patent/GB0120150D0/en
Application filed filed Critical
Publication of JP2005502339A publication Critical patent/JP2005502339A/ja
Publication of JP2005502339A5 publication Critical patent/JP2005502339A5/ja
Pending legal-status Critical Current

Links

JP2003521262A 2001-08-17 2002-08-15 Derp1およびproderp1アレルゲン誘導体 Pending JP2005502339A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0120150.8A GB0120150D0 (en) 2001-08-17 2001-08-17 Novel compounds
PCT/EP2002/009122 WO2003016340A1 (en) 2001-08-17 2002-08-15 Derp1 and proderp1 allergen derivatives

Publications (2)

Publication Number Publication Date
JP2005502339A JP2005502339A (ja) 2005-01-27
JP2005502339A5 true JP2005502339A5 (enExample) 2006-01-05

Family

ID=9920622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003521262A Pending JP2005502339A (ja) 2001-08-17 2002-08-15 Derp1およびproderp1アレルゲン誘導体

Country Status (6)

Country Link
US (2) US20040234538A1 (enExample)
EP (1) EP1417226A1 (enExample)
JP (1) JP2005502339A (enExample)
CA (1) CA2457163A1 (enExample)
GB (1) GB0120150D0 (enExample)
WO (1) WO2003016340A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300681A1 (en) * 2002-10-02 2004-05-04 Diamyd Medical Ab Formulation of glutarmic acid decarboxylase (gad65) and serum albumin
GB0304424D0 (en) * 2003-02-26 2003-04-02 Glaxosmithkline Biolog Sa Novel compounds
CA2523402A1 (en) * 2003-04-25 2004-11-11 Novozymes A/S Group 1 mite polypeptide variants
WO2006026994A1 (en) * 2004-09-09 2006-03-16 Alk-Abelló A/S Crystal structure of house dust mite allergen der p 1
FR2889592B1 (fr) * 2005-08-03 2008-09-12 Inst Nat Agronomique Paris Gri Procede pour tester l'aptitude d'une composition a provoquer une reaction allergique croisee avec un allergene derive de l'arachide
EP1835031A1 (en) * 2006-03-14 2007-09-19 Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans
WO2008154350A2 (en) * 2007-06-08 2008-12-18 Alba Therapeutics Corporation Use of tight junction agonists to suppress immune responses
NL2014882B1 (en) 2015-05-29 2017-01-31 Citeq B V Allergy-specific immunotherapy compositions for use in the treatment of house-dust mite allergy.
GB201806819D0 (en) * 2018-04-26 2018-06-13 Univ Gent Compositions for active immunotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433948A (en) * 1990-02-13 1995-07-18 Thomas; Wayne R. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
US6849427B1 (en) * 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
EP1043032A3 (en) * 1994-07-29 2000-11-15 Kenneth Houlbrook Use of moisture and heat for de-naturing house dust mite (HDM) allergen
US5670356A (en) * 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
GB9724531D0 (en) * 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6455686B1 (en) * 1998-04-17 2002-09-24 Heska Corporation Dermatophagoides nucleic acid molecules, proteins and uses thereof
WO2001029078A2 (en) * 1999-10-15 2001-04-26 Heska Corporation Method for production and use of mite group 1 proteins
GB0014288D0 (en) * 2000-06-10 2000-08-02 Smithkline Beecham Biolog Vaccine

Similar Documents

Publication Publication Date Title
JP2014527404A5 (enExample)
ES2286844T3 (es) Expresion de proteinas heterologas.
ES2552793T3 (es) Variantes de SAP y su uso
JP2003530093A5 (enExample)
JP2005511019A5 (enExample)
JP2013501038A5 (enExample)
JP2006149406A5 (enExample)
JP2006501825A5 (enExample)
CN1300294A (zh) β-淀粉样前体蛋白和泛素-B的移码突变体和它们的用途
JP2002510494A5 (enExample)
JPH07509228A (ja) 副甲状腺ホルモンおよび副甲状腺ホルモン関連ペプチドの類似体:それらの合成および骨粗鬆症の処置のための用途
JP2008507298A5 (enExample)
JP2001081042A5 (enExample)
JP2008529558A5 (enExample)
JP2008536483A5 (enExample)
JP2009540801A5 (enExample)
JP2005102701A5 (enExample)
JP2010500399A5 (enExample)
JP2005502339A5 (enExample)
JP2004194588A5 (enExample)
CA2513836A1 (en) Hypoallergenic der p1 and der p3 proteins from dermatographoides pteronyssinus
JP2003503355A5 (enExample)
JP2005512518A5 (enExample)
JP2020509770A5 (enExample)
JP2013545761A5 (enExample)